Taken together, GNAS mutant in cfDNA, definitively derived from the primary lesions harboring the identical mutation, can serve as a specific predictor of IPMN differentiating from other PCNs. Here, GNAS is linked to pancreatic intraductal papillary-mucinous neoplasm.